A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Xp13512/Gsk1838262 in the Treatment of Patients With Primary Restless Legs Syndrome
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 30
(suppl_3)
◽
pp. iii523-iii524
Keyword(s):
2012 ◽
Vol 35
(4)
◽
pp. 165-173
◽
Keyword(s):
Keyword(s):
Keyword(s):